Cyclacel Pharmaceuticals, Inc. (CYCC)
NASDAQ: CYCC · Real-Time Price · USD
2.250
-0.500 (-18.18%)
May 14, 2025, 12:59 PM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2018 FY 2016 FY 2015 FY 2014 2016 - 2018
Period Ending
Dec '23 Dec '18 Dec '16 Dec '15 Dec '14 2016 - 2018
Cancer Medicines
420.00K
Log In
Log In
Log In
Log In
Upgrade
Cancer Medicines Growth
180.00%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2018 FY 2016 FY 2015 FY 2014 2016 - 2018
Period Ending
Dec '23 Dec '18 Dec '16 Dec '15 Dec '14 2016 - 2018
United Kingdom
420.00K
Log In
Log In
Log In
Log In
Upgrade
United Kingdom Growth
180.00%
Log In
Log In
Log In
Log In
Upgrade